Analyst Ratings For bluebird bio Inc (NASDAQ:BLUE)
Today, Cantor Fitzgerald set its price target on bluebird bio Inc (NASDAQ:BLUE) to $122.00 per share.
There are 14 Buy Ratings, 8 Hold Ratings, 2 Sell Ratings, no Strong Buy Ratings on the stock.
The current consensus rating on bluebird bio Inc (NASDAQ:BLUE) is Buy with a consensus target price of $212.05 per share, a potential 30.57% upside.
Some recent analyst ratings include
- 9/5/2018-bluebird bio Inc (NASDAQ:BLUE) had its Buy rating reiterated by William Blair
- 8/6/2018-bluebird bio Inc (NASDAQ:BLUE) had its Hold rating reiterated by Maxim Group
- 8/6/2018-bluebird bio Inc (NASDAQ:BLUE) had its Buy rating reiterated by Cowen
- 8/3/2018-bluebird bio Inc (NASDAQ:BLUE) had its Buy rating reiterated by SunTrust Banks with a $223.00 price target
- 8/3/2018-bluebird bio Inc (NASDAQ:BLUE) had its Buy rating reiterated by BMO Capital Markets with a $208.00 price target
- 8/2/2018-bluebird bio Inc (NASDAQ:BLUE) had its Buy rating reiterated by Piper Jaffray Companies
Recent Insider Trading Activity For bluebird bio Inc (NASDAQ:BLUE)
bluebird bio Inc (NASDAQ:BLUE) has insider ownership of 3.00% and institutional ownership of 98.45%.
- On 8/30/2018 Jeffrey T Walsh, Insider, sold 20,000 with an average share price of $175.40 per share and the total transaction amounting to $3,508,000.00.
- On 8/20/2018 Alison Cecily Finger, Insider, sold 259 with an average share price of $158.07 per share and the total transaction amounting to $40,940.13.
- On 8/10/2018 Jeffrey T Walsh, Insider, sold 1,500 with an average share price of $156.93 per share and the total transaction amounting to $235,395.00.
- On 8/6/2018 Philip D Gregory, Insider, sold 1,800 with an average share price of $156.61 per share and the total transaction amounting to $281,898.00.
- On 8/2/2018 Jeffrey T Walsh, Insider, sold 21,500 with an average share price of $152.02 per share and the total transaction amounting to $3,268,430.00.
- On 7/11/2018 David Davidson, Insider, sold 3,000 with an average share price of $180.15 per share and the total transaction amounting to $540,450.00.
- On 7/9/2018 Jason Cole, Insider, sold 5,126 with an average share price of $170.25 per share and the total transaction amounting to $872,701.50.
Recent Trading Activity for bluebird bio Inc (NASDAQ:BLUE)
Shares of bluebird bio Inc closed the previous trading session at 161,88 −3,07 1,86 % with 160.8 shares trading hands.